Abstract
Background
Myocardial imaging with bone agents such as Tc-99 m PYP and HMDP has assumed a central role in the evaluation of patients with suspected transthyretin (TTR) amyloidosis. Visual scoring (VS) (0–3 +) and the heart to contralateral lung ratio (HCL) classify many patients as equivocal when mediastinal uptake is apparent but cannot be further differentiated into myocardial uptake versus blood pool. SPECT imaging has been recommended but current reconstruction protocols frequently produce amorphous mediastinal activity that also fails to discriminate between myocardial activity and blood pool. We hypothesized that interactive filtering interactively using a deconvolving filter would improve this.
Methods
We identified 176 sequential patients referred for TTR amyloid imaging. All patients had planar imaging, 101 had planar imaging with a large field of view camera that allowed HCL measurements. SPECT imaging was performed on a 3-headed digital camera with lead fluorescence attenuation correction. One study was excluded for technical reasons. We created software to allow interactive filtering while reconstructing the images then overlay them on attenuation mu maps to assist localization of myocardial/mediastinal uptake. Conventional Butterworth and an interactive inverse Gaussian filters were employed to differentiate myocardial uptake from residual blood pool. We defined “clean blood pool” (CBP) as recognizable blood pool with no activity in the surrounding myocardium. A scan was determined diagnostic if it showed CBP, positive uptake or no identifiable mediastinal uptake.
Results
76/175 (43%) were equivocal (1 +) by visual uptake. Of these 22 (29%) were diagnostic by Butterworth but 71 (93%) were by inverse gaussian (p < .0001). 71/101 (70%) were equivocal by HCL (1–1.5). Of these, 25 (35%) were diagnostic by Butterworth but 68 (96%) were diagnostic by inverse gaussian (p < .0001). This was driven by a greater than threefold increase in the identification of CBP by inverse gaussian filtering.
Conclusion
CBP can be identified in the vast majority of patients with equivocal PYP scans using optimized reconstruction and can greatly reduce the number of equivocal scans.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12350-023-03291-7/MediaObjects/12350_2023_3291_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12350-023-03291-7/MediaObjects/12350_2023_3291_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12350-023-03291-7/MediaObjects/12350_2023_3291_Fig3_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12350-023-03291-7/MediaObjects/12350_2023_3291_Fig4_HTML.jpg)
Similar content being viewed by others
Abbreviations
- TTR:
-
Transthyretin
- VS:
-
Visual scoring
- HCL:
-
Heart to contralateral lung ratio
- CBP:
-
Clean blood pool
- PYP:
-
Technetium-99 m pyrophosphate
- HMDP:
-
Technetium-99 m-hydroxymethylene diphosphonate
References
Gertz MA, Brown ML, Hauser MF, Kyle RA. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis. Arch Intern Med 1987;147:1039‐44.
Poterucha TJ, Elias P, Bokhari S, Einstein AJ, DeLuca A, Kinkhabwala M. Diagnosing transthyretin cardiac amyloidosis by technetium Tc 99m pyrophosphate. Cardiovascular Imaging 2021;14:1221‐31.
Abulizi M, Cottereau AS, Guellich A, Vandeventer S, Galat A, Van Der Gucht A, et al. Early-phase myocardial uptake intensity of (99m)Tc-HMDP vs (99m)Tc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis. J Nucl Cardiol 2018;25:217‐22.
Dorbala S, Bokhari S, Glaudemans AWJM, Miller E, Bullock-Palmer R, Slart RHJA et al. 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) and 99mTechnetiumhydroxymethylene diphosphonate (HMDP) imaging for transthyretin cardiac amyloidosis. https://www.asnc.org/files/19110%20ASNC%20AND%20EANM%20Amyloidosis%20Practice%20Points%20WEB(2).pdf; 2019.
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 2018;379:1007‐16.
Dorbala S, Bokhari S, Miller E, Bullock-Palmer R, Soman P, Thompson R. 99mTechnetium-pyrophosphate imaging for transthyretin cardiac amyloidosis. https://www.asnc.org/files/19110%20ASNC%20Amyloid%20Practice%20Points%20WEB(2).pdf. 2019.
Bokhari S, Castano A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 2013;6:195‐201.
Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base and standardized methods of imaging. Circulation 2021;14:e000029.
Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 2005;46:1076‐84.
Hansen CL. The role of the translation table in cardiac image display. J Nucl Cardiol 2006;13:571‐5.
Hansen CL. The “ramp filter” artifact in filtered back projection is due to attenuation not ramp filtering. Nucl Med Commun 2022;43:694‐700.
Hansen CL. Digital image processing for clinicians, part II: filtering. J Nucl Cardiol 2002;9:429‐37.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarises the contents of the paper and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.
The authors have also provided an audio summary of the article, which is available to download as ESM, or to listen to via the JNC/ASNC Podcast.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hansen, C.L. Improving evaluation for TTR amyloidosis by interactive filtering of Tc-99 m PYP SPECT images. The role for “clean blood pool” imaging. J. Nucl. Cardiol. 30, 2418–2426 (2023). https://doi.org/10.1007/s12350-023-03291-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-023-03291-7